Skip to main content
SpringerLink
Log in

Neue Darmparasiten — Therapeutische Konzepte

  • Chapter
Ökosystem Darm VIII

  • 48 Accesses

Zusammenfassung

Die „neuen Darmparasiten“ sind nur teilweise wirklich neu. Neu ist vielmehr, daß ihre Bedeutung für Mikrobiologen und Kliniker erst in den letzten Jahren offenbar geworden ist. Verbesserte diagnostische Möglichkeiten haben dazu beigetragen, sie sicherer und schneller erkennen zu können. Eine verstärkte Reisetätigkeit importierte Darmparasiten aus Entwicklungsländern, in denen sie mit hoher Prävalenz vorkommen, auch in die Industrieländer, in denen sie bisher eine Rarität waren. Die „neuen Darmparasiten“ sind im Prinzip für einen ansonsten gesunden Menschen relativ harmlos. Das Aufkommen neuer Krankheiten (z.B. AIDS) oder neuer Therapiemöglichkeiten (z.B. antineopla-stische Chemotherapie, Organtransplantation, Knochenmarktransplantation) hat allerdings dazu geführt, daß diese Erreger bei immer mehr Personen eine klinisch manifeste und therapiebedürftige Erkrankung hervorrufen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ackers JP (1997) Gut coccidia - Isospora, Cryptosporidium, Cyclospora and Sarcocystis. Semin Gastrointestin Dis 8:33–44

    CAS  Google Scholar 

  2. Bissuel F, Cotte L, Rabodonirina M, Rougier P, Piens MA, Trepo C (1994) Paromomycin: An effective treatment for cryptosporidial diarrhea in patients with AIDS. Clin Infect Dis 18:447–449

    Article  PubMed  CAS  Google Scholar 

  3. Carr A, Marriott D, Field A, Vasak E, Cooper DA (1998) Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy. Lancet 351:256–261

    Article  PubMed  CAS  Google Scholar 

  4. Conteas CN, Didier ES, Berlin OGW (1997) Workup of gastrointestinal microsporidiosis. Dig Dis 15:330–345

    Article  PubMed  CAS  Google Scholar 

  5. Desportes-Livage I (1998) Human microsporidioses. Current opinion in infectious diseases 11:177–181

    Google Scholar 

  6. Dietrich DT, Lew EA, Kotler DP, Poles MA, Orenstein JM (1994) Treatment with albendazole for intestinal disease due to Enterocytozoon bieneusi in patients with AIDS. J Infect Dis 169:178–183

    Article  Google Scholar 

  7. Diosino D, Ibba Manneschi L, Di Lollo S, Orsi A, Sterrantino G, Meli M, Gabbrielli M, Tani A, Papucci A, Leoncini F (1997) Enterocytozoon bieneusi in AIDS: Symptomatic relief and parasite change after furazolidone. J Clin Pathol 50:472–476

    Article  Google Scholar 

  8. Diosino D, Orsi A, Sterrantino G, Meli M, Di Lollo S, Ibba Maneschi L, Trotta M, Pozzi M, Sani L, Leoncini F (1998) Chronic cryptosporidiosis in patients with AIDS. Stable remission and possible eradication after long term, low dose azithromycin. J Clin Pathol 51:138–142

    Google Scholar 

  9. Dore GJ, Marriott DJ, Hing MC, Harkness JL, Field AS (1995) Disseminated microsporidiosis due to Septata intestinalis in nine patients infected with the human immunodeficiency virus: Response to therapy with albendazole. Clin Infect Dis 21:70–76

    Article  PubMed  CAS  Google Scholar 

  10. Fichtenbaum CJ, Ritchie DJ, Powderly WG (1993) Use of paromomycin for treatment of cryptosporidiosis in patients with AIDS. Clin Infect Dis 16:298–300

    Article  PubMed  CAS  Google Scholar 

  11. Greenberg PD, Cello PD (1996) Treatment of severe diarrhea caused by Cryptosporidium parvum with oral bovine immunoglobulin concentrate in patients with AIDS. J Acquir Immune Def Syndr Hum Retrovirol 13:348–354

    Article  CAS  Google Scholar 

  12. Guarino A, Canani RB, Spagnuolo MI, Bisceglia M, Boccia MC, Rubino A (1998) In vivo and in vitro efficacy of octreotide for treatment of enteric cryptosporidiosis. Dig Dis Sei 43:436–441

    Article  CAS  Google Scholar 

  13. Hoepelman (1996) Human cryptosporidiosis. International Journal of STD & AIDS 7 (Suppl. l):28–33

    Article  Google Scholar 

  14. Hoge CW, Shlim DR, Ghimire M, Rabold JG, Pandey P, Walch A, Rajah R, Gaudio P, Echeverria P (1995) Placebo-controlled trial of co-trimoxazole for cyclospora infections among tra- vellers and foreign residents in Nepal. Lancet 345:691–693

    Article  PubMed  CAS  Google Scholar 

  15. Holmberg SD, Moorman AC, Von Bargen JC, Palella FJ, Loveless MO, Ward DJ, Navin TR (1998) Possible effectiveness of clarithromycin and rifabutin for cryptosporidiosis chemo- prophylaxis in HIV disease. JAMA 279:384–386

    Article  PubMed  CAS  Google Scholar 

  16. Jelinek T, Lotze M, Eichenlaub S, Löscher T, Nothdruft HD (1997) Prevalence of infection with Cryptosporidium parvum and Cyclospora cayetanensis among international travellers. Gut 41:801–804

    Article  PubMed  CAS  Google Scholar 

  17. Jelinek T, Peyerl G, Loscher T, von Sonnenburg F, Nothdruft HD (1997) The role of Blastocysts hominis as a possible intestinal pathogen in travellers. J Infection 35:63–66

    Article  CAS  Google Scholar 

  18. Kelly P, Lungu F, Keane E, Baggaly R, Kazembe F, Pobee J, Farthing M (1996) Albendazole chemotherapy for treatment of diarrhoea in patients with AIDS in Zambia: a randomized double blind controlled trial. B Med J 312:1187–1191

    CAS  Google Scholar 

  19. Lindhorst E, Long E (1998) Cyclospora cayetanensis - Ein humanpathogenes intestinales Protozoon von zunehmender klinischer Bedeutung. Dtsch med Wschr 123:504–509

    Article  PubMed  CAS  Google Scholar 

  20. Mac Kenzie WR, Hoxie NJ, Proctor ME, Gradus MS et al. (1994) A massive outbreak in Milwaukee of Cryptosporidium infection transmitted through the public water supply. N Engl J Med 331:161–167

    Article  PubMed  CAS  Google Scholar 

  21. Molina JM, Oksenhendler E, Beauvais B, Sarfati C, Jaccard A, Derouin F, Modai J (1995) Disseminated microsporidiosis due to Septata intestinalis in patients with AIDS: Clinical features and response to albendazole therapy. J Infect Dis 171:245–249

    Article  PubMed  CAS  Google Scholar 

  22. Molina JM, Goguel J, Sarfati C, Chastang C, Desportes-Livage I, Michiels JF et al. (1997) Potential efficacy of fumagillin in intestinal microsporidiosis due to Enterocytozoon bieneusi infections in patients with HIV infection; results of a drug screening study. AIDS 11:1603–1610

    Article  PubMed  CAS  Google Scholar 

  23. Mohri H, Fujita H, Asakura Y, Katoh K, Okamoto R, Tanabe J, Harano H, Noguchi T, Inayama Y, Smano T, Okubo T (1995) Case report: Inhalation therapy of paromomycin is effective for respiratory infection and hypoxia by Cryptosporidium with AIDS. Am J Med Sci 309:60–62.

    Article  PubMed  CAS  Google Scholar 

  24. Pape JW, Verdier RI, Johnson WD (1989) Treatment and prophylaxis of Isospora belli infection in patients with the acquired immunodeficiency syndrome. N Engl J Med 320:1044–1047.

    Article  PubMed  CAS  Google Scholar 

  25. Pape JW, Verdier RI, Boncy M, Boncy J, Johnson WD (1994) Cyclospora infection in adults infected with HIV. Clinical manifestations, treatment, and prophylaxis. Ann Inter Med 121:654–657

    CAS  Google Scholar 

  26. Petry F (1998) Epidemiological study of Cryptosporidium parvum in sera of persons from Germany. Infection 26:7–11

    Google Scholar 

  27. Poppinger J, Gläßel F, Schäfer B, Stroms A, Schlote F (1997) Erfolgreiche Durchfallbehandlung mit Saccharomyces boulardii bei schwer behandelbaren HIV-Diarrhoen. Der Kassenarzt 37:37–43

    Google Scholar 

  28. Rehg JE (1991) Anti-Cryptosporidial activity of macrolides in immunosuppressed rats. J Protzool 38:228S–230S

    CAS  Google Scholar 

  29. Rump JA, Arndt R, Arnold A, Bendick C, Dichtelmüller H, Franke M, Helm EB, Jäger H (1992) Treatment of diarrhoea in human immunodeficiency virus-infected patients with immunoglobulins from bovine colostrum. Clin Invest 70:588–594

    Article  CAS  Google Scholar 

  30. Saint-Marc T, Blehaut M, Musial C, Touraine JL (1995) Diarrhées en relation avec le SIDA. Essai en double aveugle de Saccharomyces cerevisiae. Sem Hêp Paris 71:735–741

    Google Scholar 

  31. Sharpsteone D, Rowbottom A, Francis N, Tovey G, Ellis D, Barrett M, Gazzard B (1997) Thalidomid: A novel therapy for microsporidiosis. Gastroenterology 112:1823–1829

    Article  Google Scholar 

  32. Simon DM, Cello JP, Valanzuela J, Levy R et al. (1995) Multicenter trial of octreotide in patients with refractory acquired immunodeficiency syndrome - associated diarrhea. Gastroenterology 108:1753–1760

    Google Scholar 

  33. Soave R (1996) Cyclospora: An overview. Clin Infect Dis 23:429–437

    Article  PubMed  CAS  Google Scholar 

  34. Soave R, Havlir D, Lancaster D, JHoseph P, Leedom L, Clough W, Geisler P, Dunne M (1993) Azithromycin (AZ) therapy of AIDS-related cryptosporidial diarrhea (CD): A multicenter, placebo-controlled, double-blind study. 33. ICAAC, Abstr. 405

    Google Scholar 

  35. Sobottka I, Albrecht H, Schäfer H, Schottelius J, Visvesvara GS, Laufs R, Schwartz DA (1995) Disseminated Encephalitozoon (Septata) intestinalis infection in a patient with AIDS: Novel diagnostic approaches and autopsy-confirmed parasitological cure following treatment with albendazole. J Clin Microbiol 33:2948–2952

    PubMed  CAS  Google Scholar 

  36. Thimme R, Opitz O, Weiner S, Fuhrmann K, Blum HE, Kreisel W (1997) Erfolgreiche Therapie der Cryptosporidien-Enteritis bei AIDS-Patienten durch eine Kombination von Paromomycin und Albendazol. Chemotherapie Journal 6 (Suppl. 15):51, Pa 80

    Google Scholar 

  37. Van Gool T, Vetter JCM, Weinmayr B, Van Dam A, Derouin F, Dankert J (1997) High seropre-valence of Encephalitozoon species in immunocompetent subjects. J Infect Dis 175:1020–1024

    Article  PubMed  Google Scholar 

  38. Variyam EP (1998) Intestinal parasitic infections. Current Opinion in Gastroenterology 15:50–56

    Google Scholar 

Download references

Authors
  1. W. Kreisel
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Pathologisch-Anatomisches Institut, Universität Erlangen-Nürnberg, Krankenhausstraße 8-10, D-91054, Erlangen, Germany

    Thomas Kirchner

  2. Medizinische Klinik II, Klinikum der Johann Wolfgang Goethe-Universität, Theodor-Stern-Kai 7, D-60590, Frankfurt am Main, Germany

    Bernhard Lembcke

  3. Institut für Medizinische Mikrobiologie und Hygiene, Hermann-Herder-Straße 11, D-79104, Freiburg, Germany

    Manfred Kist

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Kreisel, W. (1999). Neue Darmparasiten — Therapeutische Konzepte. In: Kirchner, T., Lembcke, B., Kist, M. (eds) Ökosystem Darm VIII. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59963-7_28

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-59963-7_28

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-64837-6

  • Online ISBN: 978-3-642-59963-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation